Related Experiment Videos
[Allergic broncho-pulmonary tuberculosis--a case without bronchial asthma].
W Naumnik1, E Chyczewska, E Swidzińska
1Kliniki Chorób Płuc i Gruźlicy AM w Białymstoku.
Pneumonologia I Alergologia Polska
|September 29, 2001
Summary
Allergic bronchopulmonary aspergillosis (ABPA), a lung disease caused by Aspergillus fumigatus, presents with asthma and inflammation. This case highlights ABPA
Area of Science:
- Medical Mycology
- Pulmonology
- Immunology
Background:
- Aspergillus fumigatus is a common fungus that can cause various lung diseases.
- Allergic bronchopulmonary aspergillosis (ABPA) is an immune-mediated lung disease characterized by asthma, eosinophilia, and bronchiectasis.
Observation:
- A 28-year-old male presented with symptoms indicative of ABPA, including pulmonary opacities, mucus impaction, positive Aspergillus skin tests, and elevated IgE levels.
- The patient initially responded to a 6-month course of corticosteroid therapy.
Findings:
- Despite initial improvement, the patient experienced a relapse of ABPA symptoms after a 2-year period of remission.
- Repeat corticosteroid treatment was initiated to manage the exacerbation.
Implications:
- This case underscores the chronic and relapsing nature of ABPA, even after initial treatment.
- Effective long-term management strategies are crucial for patients with recurrent ABPA.
- Further research into the immunopathogenesis of ABPA may lead to novel therapeutic approaches.